Caredx Inc Receivables Turnover Ratio (CDNA), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Caredx Inc   (NASDAQ: CDNA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Caredx Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Caredx Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 8.16, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Caredx Inc in Mar 31 2026 quarter, has decreased to 45 days, compared to 55 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 116 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 760 to 957.

What is Receivable Turnover Ratio?
What is Caredx Inc Selling?


What is Receivable Turnover Ratio?





CDNA Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change -37.63 % -34.02 % -28.19 % 1.82 % 18.85 %
Y / Y Revenue Change 38.99 % 25.19 % 20.72 % -6.06 % 17.54 %
Receivable Turnover Ratio (TTM) 8.16 6.62 5.7 5.05 5.15
CDNA's Total Ranking # 957 # 760 # 2231 # 1247 # 821
Accounts Receivable average collection period days 45 55 64 72 71
Seq. Receivable Change 4.59 % -10.9 % -28.97 % -5.77 % 10.65 %
Seq. Revenue Change 8.59 % 8.33 % 15.43 % 2.35 % -2.19 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 117
Overall Market # 957

Receivable Turnover Ratio Statistics
High Average Low
0.97 0.67 0.47
(Mar 31 2026)   (Jun 30 2016)






Financial Statements
Caredx Inc 's Accounts Receivable $ 45 Millions Visit CDNA's Balance sheet
Caredx Inc 's Sales TTM $ 413 Millions Visit CDNA's Income Statement
Sources of CDNA's Revenues Visit CDNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CDNA's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CDNA's Growth Rates CDNA's Roa CDNA's Inventory Turnover Ratio CDNA's Dividend Comparisons
CDNA's Profitability Ratios CDNA's Roi CDNA's Asset Turnover Ratio CDNA's Dividend Growth
CDNA's Valuation Ratios CDNA's Roe CDNA's Financial Strength Ratios CDNA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Biorestorative Therapies Inc   25.41 $ 0.363  Millions$ 0.014  Millions
Jaguar Health Inc   24.65 $ 29.569  Millions$ 1.200  Millions
Kiniksa Pharmaceuticals International Plc  24.63 $ 754.045  Millions$ 30.618  Millions
Polomar Health Services, Inc.  24.47 $ 1.649  Millions$ 0.067  Millions
Agenus Inc  24.33 $ 123.866  Millions$ 5.091  Millions
Igc Pharma Inc   23.44 $ 1.166  Millions$ 0.050  Millions
Cytomx Therapeutics Inc   23.09 $ 35.542  Millions$ 1.539  Millions
Siga Technologies Inc  22.41 $ 93.777  Millions$ 4.186  Millions
Lipocine Inc   22.09 $ 2.002  Millions$ 0.091  Millions
Ataibeckley Inc   21.56 $ 3.488  Millions$ 0.162  Millions
Fonar Corporation  21.15 $ 105.338  Millions$ 4.981  Millions
Neuraxis Inc   20.94 $ 4.282  Millions$ 0.204  Millions
Vystar Corporation  20.58 $ 0.048  Millions$ 0.002  Millions
Lifemd Inc   19.91 $ 177.869  Millions$ 8.934  Millions
Longeveron Inc   19.07 $ 1.216  Millions$ 0.064  Millions
Sonida Senior Living Inc   18.82 $ 411.850  Millions$ 21.878  Millions
Voyager Therapeutics Inc   17.99 $ 36.494  Millions$ 2.029  Millions
Nutriband Inc   16.79 $ 1.803  Millions$ 0.107  Millions
Bioadaptives Inc   16.64 $ 0.024  Millions$ 0.001  Millions
Premier Air Charter Holdings Inc   16.33 $ 33.205  Millions$ 2.033  Millions
Bioage Labs Inc   15.90 $ 10.316  Millions$ 0.649  Millions
Escalon Medical Corp   15.15 $ 11.445  Millions$ 0.756  Millions
Nurix Therapeutics Inc   15.11 $ 71.779  Millions$ 4.750  Millions
Rosecliff Acquisition Corp I  15.05 $ 23.433  Millions$ 1.557  Millions
Lexicon Pharmaceuticals Inc   14.91 $ 69.643  Millions$ 4.670  Millions
Qhslab Inc   14.80 $ 2.775  Millions$ 0.188  Millions
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions

Date modified: 2026-06-22T14:32:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.